Page last updated: 2024-10-24

verapamil and Multiple System Atrophy Syndrome

verapamil has been researched along with Multiple System Atrophy Syndrome in 1 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartels, AL1
Willemsen, AT1
Kortekaas, R1
de Jong, BM1
de Vries, R1
de Klerk, O1
van Oostrom, JC1
Portman, A1
Leenders, KL1

Other Studies

1 other study available for verapamil and Multiple System Atrophy Syndrome

ArticleYear
Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.
    Journal of neural transmission (Vienna, Austria : 1996), 2008, Volume: 115, Issue:7

    Topics: Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain Mapping; C

2008